相关实验视频

Updated: Jun 14, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

活细胞侵入性表型化揭示了ALK2作为LKB1-突变肺癌的治疗标

Junghui Koo¹, Chang-Soo Seong¹, Rebecca E Parker^1,2

¹Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.

Cancer research

|August 29, 2024

概括

在KRAS驱动的肺癌中,LKB1的丧失通过BMP6信号传递促进了入侵. 抑制ALK2/BMP6轴在治疗LKB1-突变肺瘤方面表现有前途.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

瘤的入侵和转移对于癌症的进展至关重要.
由KRAS驱动的肺癌亚型表现出不同的入侵模式,影响生长和治疗反应.
在临床前模型中,针对与入侵相关的增长漏洞仍然是一个挑战.

研究的目的:

开发一种用于选可向信号通路的实验系统,用于选KRAS驱动的肺腺癌亚型中与早期3D侵入相关的可向信号通路.
确定驱动不同KRAS突变肺癌亚型侵袭的特定分子机制.

主要方法:

在3D入侵矩阵中利用支气管上皮细胞的活细胞成像.
进行了转录基因分析,以确定与侵袭相关的基因表达变化.
研究了LKB1,BMP6和ALK2信号在肺癌模型中的作用.

主要成果:

确定了突变的LKB1特异性BMP6上调,这驱动了肝素表达和铁调节的生长.
证明完整的LKB1通常会限制ALK2/BMP6驱动的生长.
在临床前模型中,通过使用临床阶段抑制剂抑制ALK2/BMP6轴,显示出强大的瘤生长抑制作用.
在人类LKB1突变肺瘤中观察到BMP6表达升高.

结论:

在肺癌中,LKB1作为铁介导生长的调节剂.
抑制ALK2/BMP6信号通路代表了对LKB1-突变肺癌的有前途的治疗策略.
这一发现为LKB1-突变肺癌患者提供了快速可翻译的治疗脆弱性.

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...